Tag: pharmaceuticals
-
Space Institute Funds Medical Product Commercialization
National Space Biomedical Research Institute in Houston will support the commercialization of two health care products made by small U.S. companies. The awards of $100,000 each were made by the institute’s Space Medicine and Related Technologies Commercialization Assistance Program (SMARTCAP) to ACell Inc., of Columbia, Maryland and Enterade USA of Newberry, Florida. SMARTCAP provides seed…
-
Small Business Grant Awarded for Artificial Pancreas Insulin
Biodel Inc., a biopharmaceutical company in Danbury, Connecticut, has received a Small Business Innovation Research (SBIR) grant to develop concentrated faster-acting insulin formulations for use in an artificial pancreas. The two-year grant totaling $582,473 was awarded by the National Institute of Diabetes and Digestive and Kidney Diseases of National Institutes of Health (NIH). Biodel notes…
-
Lymphoma Drug Found to Uncover Dormant HIV
A team led by researchers at University of North Carolina in Chapel Hill have found a drug given to fight lymphoma was able to dislodge heretofore hidden virus in patients with HIV. The findings appear online in this week’s issue of the journal Nature (paid subscription required). The researchers, led by UNC medical professor David…
-
$2.6B Venture Fund Aims for Health Care, Energy Companies
New Enterprise Associates Inc., a venture capital company in Chevy Chase, Maryland, says it has closed its 14th fund with $2.6 billion in capital. New Enterprise says the new fund is its third consecutive property exceeding $2.5 billion, and brings the company’s total committed capital to more than $13 billion across all of its funds.…
-
Biopharma Secures $38.5 Million in Series D Funds
Chiasma Inc., a biopharmaceutical company in Jerusalem, Israel, has closed its $38.5 million series D funding round, the fourth cycle of financing after initial start-up. The round was led by by new investor Abingworth and current investor MPM Capital, with participation from current share holders 7 Med Health Ventures, ARCH Venture Partners, F3 Ventures, and…
-
VC Funding Cut for U.S. Firms, Science Companies Take Hit
Venture capital investments in U.S.-based companies are down for the second quarter of 2012, with software and Internet companies favored over enterprises based on scientific discoveries. According to Dow Jones VentureSource, a financial industry research service, companies in the U.S. raised $8.1 billion in 863 deals during the second quarter of 2012, a nine percent…
-
Nanoscale Drug Delivery Process Helps Cancer Treatment
Researchers from Yale University’s medical and engineering faculties in New Haven have devised a new technique for delivering cancer treatments that also boosts a response by the immune system. The findings of the research, funded by a National Science Foundation grant, and led by Yale University biomedical engineering professor Tarek Fahmy (pictured right) are found…
-
Strategy Proposed for Overcoming Resistance to Cancer Drug
Researchers in the U.K., with colleagues from the U.S. and Sweden, have recommended a way to overcome the resistance of cancer cells to the drug crizotinib, which recently showed positive results in its first trial in children with cancer. The findings are published online this week in the journal Cancer Cell (paid subscription required). Louis…
-
Janssen to Fund Research/Modeling for Multiple Sclerosis
Janssen Research and Development, a subsidiary of Johnson & Johnson in Titusville, New Jersey, will sponsor a research and systems modeling project to uncover the genetic and biologic causes of multiple sclerosis. The $5.4 million initiative will be part of Janssen’s Healthy Minds initiative, a program launched in 2011 to accelerate progress on neurologic and…
-
Trial Shows Platelet Drug Benefit for Aplastic Anemia
A clinical trial has shown eltrombopag, a drug originally designed to stimulate production of platelets from bone marrow, can raise blood cell levels in some people with severe aplastic anemia, who have failed all standard therapies. The findings of the phase 2 trial conducted by the National Heart, Lung, and Blood Institute (NHLBI), and other…